Gillies Hunter
Insider CIK 1868997 · AVTE Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AVTE Aerovate Therapeutics, Inc | M Exercise deriv | 2024-06-13 | 2024-06-14 | 6,000 | — | $0 | 83,510 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | M Exercise | 2024-06-13 | 2024-06-14 | 6,000 | $2.14 | $12.8K | 11,602 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | S Sale | 2024-06-13 | 2024-06-14 | 6,000 | $24.50 | $147.0K | 5,602 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | M Exercise deriv | 2024-05-17 | 2024-05-17 | 4,000 | — | $0 | 11,324 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | M Exercise | 2024-05-17 | 2024-05-17 | 4,000 | $2.14 | $8.6K | 9,602 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | S Sale | 2024-05-17 | 2024-05-17 | 3,914 | $21.07 | $82.5K | 5,688 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | S Sale | 2024-05-17 | 2024-05-17 | 86 | $21.86 | $1.9K | 5,602 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | M Exercise deriv | 2024-04-17 | 2024-04-19 | 503 | — | $0 | 2,511 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | M Exercise deriv | 2024-04-17 | 2024-04-19 | 3,497 | — | $0 | 539 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | S Sale | 2024-04-17 | 2024-04-19 | 3,689 | $22.30 | $82.3K | 3,562 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | M Exercise | 2024-04-17 | 2024-04-19 | 4,000 | $1.74 | $7.0K | 7,251 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | S Sale | 2024-04-17 | 2024-04-19 | 311 | $23.33 | $7.3K | 3,251 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | M Exercise deriv | 2024-03-28 | 2024-04-01 | 9,000 | — | $0 | 89,510 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | M Exercise | 2024-03-28 | 2024-04-01 | 9,000 | $2.14 | $19.3K | 12,251 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | S Sale | 2024-03-28 | 2024-04-01 | 9,000 | $29.50 | $265.5K | 3,251 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | M Exercise deriv | 2024-03-18 | 2024-03-20 | 3,000 | — | $0 | 98,510 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | M Exercise deriv | 2024-03-18 | 2024-03-20 | 4,000 | — | $0 | 4,036 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | S Sale | 2024-03-18 | 2024-03-20 | 613 | $26.40 | $16.2K | 3,251 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | M Exercise | 2024-03-18 | 2024-03-20 | 4,000 | $1.74 | $7.0K | 7,251 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | M Exercise | 2024-03-18 | 2024-03-20 | 3,000 | $2.14 | $6.4K | 10,251 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | S Sale | 2024-03-18 | 2024-03-20 | 6,387 | $25.81 | $164.8K | 3,864 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | M Exercise deriv | 2024-03-07 | 2024-03-11 | 8,030 | — | $0 | 101,510 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | M Exercise deriv | 2024-03-07 | 2024-03-11 | 945 | — | $0 | 15,324 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | M Exercise | 2024-03-07 | 2024-03-11 | 8,975 | $2.14 | $19.2K | 12,226 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | S Sale | 2024-03-07 | 2024-03-11 | 8,975 | $24.50 | $219.9K | 3,251 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | M Exercise deriv | 2024-02-23 | 2024-02-27 | 511 | — | $0 | 3,014 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | S Sale | 2024-02-23 | 2024-02-27 | 511 | $19.50 | $10.0K | 3,251 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | M Exercise | 2024-02-23 | 2024-02-27 | 511 | $1.74 | $889 | 3,762 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | M Exercise deriv | 2024-02-20 | 2024-02-22 | 987 | — | $0 | 8,036 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | M Exercise deriv | 2024-02-20 | 2024-02-22 | 2,502 | — | $0 | 3,525 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | S Sale | 2024-02-20 | 2024-02-22 | 898 | $20.58 | $18.5K | 3,251 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | M Exercise | 2024-02-20 | 2024-02-22 | 3,489 | $1.74 | $6.1K | 6,740 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | S Sale | 2024-02-20 | 2024-02-22 | 2,591 | $20.11 | $52.1K | 4,149 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | A Award deriv | 2024-01-22 | 2024-01-24 | 66,586 | — | $0 | 66,586 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | M Exercise deriv | 2024-01-17 | 2024-01-19 | 4,000 | — | $0 | 6,027 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | S Sale | 2024-01-17 | 2024-01-19 | 4,000 | $19.50 | $78.0K | 3,251 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | M Exercise | 2024-01-17 | 2024-01-19 | 4,000 | $1.74 | $7.0K | 7,251 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | M Exercise deriv | 2023-12-27 | 2023-12-29 | 25 | — | $0 | 16,269 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | M Exercise deriv | 2023-12-27 | 2023-12-29 | 100 | — | $0 | 109,540 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | M Exercise | 2023-12-27 | 2023-12-29 | 125 | $2.14 | $268 | 3,376 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | S Sale | 2023-12-27 | 2023-12-29 | 125 | $24.50 | $3.1K | 3,251 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | M Exercise deriv | 2023-12-20 | 2023-12-22 | 2,924 | — | $0 | 9,023 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | M Exercise deriv | 2023-12-20 | 2023-12-22 | 1,076 | — | $0 | 10,027 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | S Sale | 2023-12-20 | 2023-12-22 | 4,000 | $19.50 | $78.0K | 3,251 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | M Exercise deriv | 2023-12-14 | 2023-12-15 | 2,700 | — | $0 | 12,744 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | M Exercise deriv | 2023-12-14 | 2023-12-15 | 7,197 | — | $0 | 10,306 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | S Sale | 2023-12-14 | 2023-12-15 | 9,897 | $19.50 | $193.0K | 3,251 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | M Exercise | 2023-12-14 | 2023-12-15 | 9,897 | $1.74 | $17.2K | 13,148 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | M Exercise deriv | 2023-12-13 | 2023-12-15 | 1,450 | — | $0 | 17,503 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | M Exercise deriv | 2023-12-13 | 2023-12-15 | 653 | — | $0 | 15,444 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | M Exercise | 2023-12-13 | 2023-12-15 | 2,103 | $1.74 | $3.7K | 5,354 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | S Sale | 2023-12-13 | 2023-12-15 | 2,103 | $19.50 | $41.0K | 3,251 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | M Exercise | 2023-12-13 | 2023-12-22 | 4,000 | $1.74 | $7.0K | 7,251 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | M Exercise deriv | 2023-05-19 | 2023-05-23 | 65 | — | $0 | 18,953 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | S Sale | 2023-05-19 | 2023-05-23 | 65 | $19.50 | $1.3K | 3,251 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | M Exercise | 2023-05-19 | 2023-05-23 | 65 | $1.74 | $113 | 3,316 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | M Exercise deriv | 2023-05-17 | 2023-05-19 | 1,090 | — | $0 | 19,018 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | M Exercise | 2023-05-17 | 2023-05-19 | 1,090 | $1.74 | $1.9K | 4,341 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | S Sale | 2023-05-17 | 2023-05-19 | 1,090 | $19.59 | $21.4K | 3,251 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | M Exercise deriv | 2023-04-21 | 2023-04-25 | 4,000 | — | $0 | 20,108 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | M Exercise | 2023-04-21 | 2023-04-25 | 4,000 | $1.74 | $7.0K | 5,960 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | S Sale | 2023-04-21 | 2023-04-25 | 4,000 | $19.50 | $78.0K | 1,960 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | A Award deriv | 2023-02-07 | 2023-02-08 | 62,000 | — | $0 | 62,000 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | A Award deriv | 2021-12-14 | 2021-12-16 | 65,433 | — | $0 | 65,433 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | A Award deriv | 2021-06-29 | 2021-07-01 | 60,300 | — | $0 | 60,300 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | A Award deriv | 2021-04-02 | 2021-07-01 | 109,640 | — | $0 | 109,640 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | A Award deriv | 2021-04-02 | 2021-07-01 | 16,294 | — | $0 | 16,294 | SEC↗ |